Evidence map›Paper›PMID 36365113›Full record

ArticlePharmaceutics2022

Antibiofilm Combinatory Strategy: Moxifloxacin-Loaded Nanosystems and Encapsulated

Rita M Pinto, Catarina Leal Seabra, Martine De Jonge, M Cristina L Martins, Patrick Van Dijck, Salette Reis, Cláudia Nunes

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. HJournal of nanobiotechnology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rita M PintoLAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-0634-2928
Catarina Leal SeabraLAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0001-9382-7047
Martine De JongeLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, 3001 Leuven, Belgium.
M Cristina L MartinsInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-6574-4794
Patrick Van DijckLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-1542-897X
Salette ReisLAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-0736-2835
Cláudia NunesLAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
Universidade do Porto · PTKU Leuven · BE

Funding

Fundação para a Ciência e Tecnologia IF/00293/2015Fundação para a Ciência e Tecnologia PTDC/NANMAT/31444/2017Fundação para a Ciência e Tecnologia SFRH/BD/130319/2017]
6 · The paper itself

Abstract

Bacterial biofilms of

Indexed as

antibiotic delivery systemsbacterial biofilmsbiofilm matrix disruptioncombined therapylipid nanoparticles

Identifiers

PMID36365113
PMCPMC9699636
OpenAlexW4307553146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.